Filing Details
- Accession Number:
- 0001179110-21-000540
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-12 16:18:15
- Reporting Period:
- 2021-01-08
- Accepted Time:
- 2021-01-12 16:18:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1070081 | Ptc Therapeutics Inc. | PTCT | Pharmaceutical Preparations (2834) | 043416587 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578850 | Gregory Neil Almstead | C/O Ptc Therapeutics, Inc. 100 Corporate Court South Plainfield NJ 07080 | Chief Technical Ops Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-01-08 | 1,300 | $27.05 | 3,688 | No | 4 | M | Indirect | By Spouse |
| Common Stock | Disposition | 2021-01-08 | 1,300 | $69.00 | 2,388 | No | 4 | S | Indirect | By Spouse |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Indirect | By Spouse |
| No | 4 | S | Indirect | By Spouse |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-01-08 | 1,300 | $27.05 | 1,300 | $27.05 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2024-01-27 | No | 4 | M | Indirect |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $490.80 | 2021-04-27 | 7 | 7 | Indirect | |
| Common Stock | Stock Option (Right to Buy) | $218.40 | 2022-01-10 | 7 | 7 | Indirect | |
| Common Stock | Stock Option (Right to Buy) | $51.00 | 2025-01-01 | 2,060 | 2,060 | Indirect |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2021-04-27 | 7 | 7 | Indirect |
| 2022-01-10 | 7 | 7 | Indirect |
| 2025-01-01 | 2,060 | 2,060 | Indirect |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to written a Rule 10b5-1 plan adopted by the spouse of the Reporting Person on November 10, 2020.
- Currently exercisable.
Billionaire Hedge Funds
